Viridian Therapeutics Inc (VRDN)

05:02 AM

What machine learning models say about Viridian Therapeutics Inc.Dollar Strength & Fast Gain Stock Trading Tips - newser.com

05:02 AM

04:34 AM

How Viridian Therapeutics Inc. stock reacts to bond yieldsMarket Performance Report & Weekly Return Optimization Plans - newser.com

04:34 AM

03:55 AM

How buybacks impact Viridian Therapeutics Inc. stock valueM&A Rumor & Technical Pattern Based Signals - newser.com

03:55 AM

12:00 PM

Tools to monitor Viridian Therapeutics Inc. recovery probability2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com

12:00 PM

11:35 AM

Retinitis Pigmentosa Market to Expand Significantly by 2034, States DelveInsight Report | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - The Globe and Mail

11:35 AM

Oct 13, 2025

Is Viridian Therapeutics Inc. stock reversal real or fakeJuly 2025 Action & Daily Volume Surge Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Is this a good reentry point in Viridian Therapeutics Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Using Ichimoku Cloud for Viridian Therapeutics Inc. technicals2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

Oct 13, 2025

What candlestick patterns are forming on Viridian Therapeutics Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Can machine learning forecast Viridian Therapeutics Inc. recoveryJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com

Oct 13, 2025

Oct 13, 2025

Is Viridian Therapeutics Inc. building a consolidation baseMarket Trend Review & Weekly Momentum Stock Picks - newser.com

Oct 13, 2025

Oct 13, 2025

Is Viridian Therapeutics Inc. stock attractive for growth ETFsMarket Movement Recap & Fast Entry Momentum Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

Why Viridian Therapeutics Inc. is moving todayWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com

Oct 12, 2025

Oct 11, 2025

Is Viridian Therapeutics Inc. (1S1) stock protected from inflationMarket Risk Report & Pattern Based Trade Signal System - newser.com

Oct 11, 2025

Oct 11, 2025

Viridian Therapeutics’ (VRDN) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025

Oct 10, 2025

Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Viridian Therapeutics supports key conferences with sponsorship initiative - Traders Union

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat

Oct 09, 2025

Oct 06, 2025

Real time alert setup for Viridian Therapeutics Inc. performanceBear Alert & Real-Time Volume Surge Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Is Viridian Therapeutics Inc. stock dividend yield sustainable2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com

Oct 05, 2025

Oct 04, 2025

Viridian Therapeutics, Inc. $VRDN Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat

Oct 04, 2025

Oct 03, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2025 - BioSpace

Oct 03, 2025

Oct 02, 2025

Viridian Therapeutics announces inducement grants under Nasdaq Listing Rule - MarketScreener

Oct 02, 2025

Sep 30, 2025

Voya Investment Management LLC Sells 1,627 Shares of Viridian Therapeutics, Inc. $VRDN - Defense World

Sep 30, 2025

Sep 29, 2025

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Sep 29, 2025

Sep 28, 2025

Is Viridian Therapeutics Inc a good long term investmentHigh Frequency Trading Trends & In-Depth Analyst Ratings Explained Simply - earlytimes.in

Sep 28, 2025

Sep 27, 2025

What Viridian Therapeutics (VRDN)'s Phase 3 TED Trial Milestones Mean For Shareholders - Sahm

Sep 27, 2025